Pharmaceuticals & Life Sciences
DevOps & CI/CD for Pharmaceuticals & Life Sciences
DevOps & CI/CD for pharmaceuticals & life sciences, built around the constraint that defines the sector: GxP validation means every system change needs documented evidence before it reaches production.
- Regulations in scope
- 5
- Systems we integrate
- 5
- Typical first release
- 6 weeks
What changes when it is pharmaceuticals & life sciences
Infrastructure as code matters most when something breaks. Rebuilding a hand-configured server from memory at 2am is the scenario it exists to prevent.
In pharmaceuticals & life sciences, GxP validation means every system change needs documented evidence before it reaches production. That single fact reshapes how devops & ci/cd has to be built here, the guardrails, the approval points and the evidence trail are design inputs rather than things bolted on before go-live.
The workload we are most often asked to take on first is literature monitoring, usually integrated against LIMS. We build the smallest thing that proves the case, put it in front of real users, and expand only what earns its keep.
Multi-model by default, so a provider outage is a routing decision rather than an incident. You own the code, the models where they are open-weight, and the documentation to run it without us.
The sector constraints we design around
- Defining constraint
- GxP validation means every system change needs documented evidence before it reaches production
- Regulations in scope
- CDSCO · US FDA 21 CFR Part 11 · EU GMP Annex 11 · GxP validation · ICH guidelines
- Systems of record
- LIMS · QMS · eTMF · SAP · pharmacovigilance databases
- Where we usually start
- batch record review
DevOps & CI/CD workloads in pharmaceuticals & life sciences
- batch record review
- adverse event intake and coding
- regulatory dossier assembly
- deviation and CAPA drafting
- literature monitoring
What is included
- Pipelines that run tests, security scans and builds on every change
- Infrastructure as code so environments are reproducible, not hand-built
- Secrets management that keeps credentials out of repositories
- Staging that genuinely resembles production
- Blue-green or canary deploys with automated rollback
- Runbooks and on-call documentation your team can actually use
Questions from this sector
Can an AI system be GxP validated?
Yes, with a documented validation approach, IQ/OQ/PQ, defined intended use, change control and evidence of consistent performance. We build the validation pack alongside the system, not afterwards.
How do you handle 21 CFR Part 11?
Audit trails, electronic signatures, access control and record integrity designed in from the start, because retrofitting them is effectively a rebuild.
Do we need Kubernetes?
Probably not. It is excellent at genuine scale and a significant operational burden below it. Managed platforms serve most teams better, and we will say so rather than sell complexity.
How often should we deploy?
As often as the work is ready. Frequent small deploys are safer than rare large ones, less changes at once, so failures are easier to isolate and reverse.
Can you work with our existing pipeline?
Yes, and usually better than replacing it. We improve what exists unless it is fundamentally unworkable.
Other capabilities for pharmaceuticals & life sciences
- AI Agent Development for Pharmaceuticals & Life Sciences
- Agentic Workflow Automation for Pharmaceuticals & Life Sciences
- LLM Application Development for Pharmaceuticals & Life Sciences
- RAG & Knowledge Retrieval for Pharmaceuticals & Life Sciences
- Chatbot Development for Pharmaceuticals & Life Sciences
- Document Processing & IDP for Pharmaceuticals & Life Sciences
- AI Copilot Development for Pharmaceuticals & Life Sciences
- Data Engineering for Pharmaceuticals & Life Sciences
- Enterprise AI Platform for Pharmaceuticals & Life Sciences
- Workflow & Integration Automation for Pharmaceuticals & Life Sciences
DevOps & CI/CD for pharmaceuticals & life sciences, worth a conversation?
Tell us the workload and the regulation it sits under. We will tell you what is realistic.
Or email bd@dtrasglobal.com · call +91 74118 77878
